Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.39B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 3 |
Citigroup
C
|
+$429M |
| 4 |
United States Oil Fund
USO
|
+$386M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$378M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$946M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$771M |
| 3 |
Alibaba
BABA
|
+$626M |
| 4 |
Tesla
TSLA
|
+$505M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$421M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.01% |
| 2 | Communication Services | 1.39% |
| 3 | Financials | 0.98% |
| 4 | Consumer Discretionary | 0.94% |
| 5 | Healthcare | 0.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
iShares Core MSCI Emerging Markets ETF
IEMG
$161B
| $8.8M | ﹤0.01% |
217,500
-2,306,651
| -91% | -$113M |
|
1852
CALL
Cirrus Logic
CRUS
$5.64B
| $8.77M | ﹤0.01% |
133,600
-265,900
| -67% | -$19.7M |
|
1853
CALL
Arrowhead Research
ARWR
$12.4B
| $8.76M | ﹤0.01% |
304,500
-228,300
| -43% | -$9.21M |
|
1854
Newmont
NEM
$140B
| $8.76M | ﹤0.01% |
193,423
-1,316,361
| -87% | -$59.4M |
|
1855
PUT
WisdomTree Japan Hedged Equity Fund
DXJ
$7.29B
| $8.75M | ﹤0.01% |
200,600
-105,900
| -35% | -$5.2M |
|
|
CCXI
1856
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
| $8.74M | ﹤0.01% |
217,500
-29,700
| -12% | -$1.26M |
|
1857
PUT
Teradyne
TER
$57B
| $8.74M | ﹤0.01% |
161,300
-187,700
| -54% | -$11.9M |
|
1858
CALL
Novavax
NVAX
$1.54B
| $8.73M | ﹤0.01% |
643,000
-430,400
| -40% | -$3.64M |
|
1859
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.09B
| $8.72M | ﹤0.01% |
+188,801
| New | +$11.1M |
|
|
NVTA
1860
DELISTED
Invitae Corporation
NVTA
| $8.72M | ﹤0.01% |
637,832
+193,562
| +44% | +$3.54M |
|
1861
PUT
Alerian MLP ETF
AMLP
$13.3B
| $8.72M | ﹤0.01% |
506,820
+120,620
| +31% | +$4.09M |
|
1862
CALL
Levi Strauss
LEVI
$8.11B
| $8.71M | ﹤0.01% |
700,800
+508,400
| +264% | +$8.99M |
|
1863
CALL
Teledyne Technologies
TDY
$29.4B
| $8.71M | ﹤0.01% |
29,300
+26,700
| +1,027% | +$9.17M |
|
1864
CALL
iShares MSCI Taiwan ETF
EWT
$11.6B
| $8.7M | ﹤0.01% |
264,000
-8,100
| -3% | -$308K |
|
|
BHVN
1865
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $8.7M | ﹤0.01% |
255,742
+85,209
| +50% | +$3.9M |
|
1866
CALL
Leidos
LDOS
$16.9B
| $8.7M | ﹤0.01% |
94,900
+60,000
| +172% | +$6.05M |
|
1867
iShares S&P Small-Cap 600 Value ETF
IJS
$8.27B
| $8.7M | ﹤0.01% |
174,040
+141,804
| +440% | +$9.83M |
|
1868
PUT
Ally Financial
ALLY
$12.9B
| $8.69M | ﹤0.01% |
602,200
+260,800
| +76% | +$6.85M |
|
1869
CALL
Ligand Pharmaceuticals
LGND
$5.52B
| $8.69M | ﹤0.01% |
191,559
-114,293
| -37% | -$6.48M |
|
1870
PUT
Zimmer Biomet
ZBH
$19B
| $8.68M | ﹤0.01% |
88,477
+51,294
| +138% | +$6.72M |
|
1871
PUT
Thomson Reuters
TRI
$44.9B
| $8.67M | ﹤0.01% |
121,197
+35,875
| +42% | +$2.8M |
|
1872
PUT
Unilever
UL
$141B
| $8.66M | ﹤0.01% |
152,178
+27,022
| +22% | +$1.7M |
|
1873
CRISPR Therapeutics
CRSP
$5.8B
| $8.65M | ﹤0.01% |
203,997
+6,396
| +3% | +$330K |
|
1874
Hasbro
HAS
$13.7B
| $8.64M | ﹤0.01% |
120,806
-40,799
| -25% | -$3.53M |
|
1875
CALL
Sempra
SRE
$55.1B
| $8.64M | ﹤0.01% |
153,000
-26,200
| -15% | -$1.86M |
|
Similar funds
Jeff Yass's Q1 2020 Portfolio in Review
As of Q1 2020, Jeff Yass held 11,456 positions worth $314B, down 9.5% from $347B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass deployed $31.5B of net new capital in Q1 2020, opening 1,843 new positions and adding to 4,539 existing holdings. Its largest new stake was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
By sector, the portfolio is most concentrated in Technology at 2% of assets, down from 2.2% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Amazon, an estimated $946M trimmed.
- Jeff Yass's largest Q1 2020 buy was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $6.39B increase.
- Jeff Yass's biggest Q1 2020 reduction was Amazon, cutting an estimated $946M.
- Jeff Yass fully exited Medicines Co in Q1 2020, selling an estimated $92M.
- Jeff Yass's ten largest holdings make up 30% of its $314B portfolio in Q1 2020.
- Jeff Yass opened 1,843 new positions and closed 1,300 in Q1 2020.
- Jeff Yass's portfolio value fell 9.5% quarter-over-quarter to $314B.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.